LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Stock List・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Closed

SectorHealthcare

7.85 -0.51

Buy

Price update 22 May 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

7.45

Max

7.91

Key metrics

By Trading Economics

Income

-4.6M

-20M

Sales

-80K

358K

P/E

Sector Avg

11.652

49.701

EPS

-2.08

Profit margin

-5,562.291

Employees

66

EBITDA

-2.9M

-20M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+187.21% upside

Dividends

By Dow Jones

Next Earnings

5 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-957K

73M

Previous open

8.36

Previous close

7.85

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Feb 2026, 13:08 UTC

Major Market Movers

Seres Shares Down After Co Pauses Drug Development, Lays Off Workers

DJ

Read

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

187.21% upside

12 Months Forecast

Average 22 USD  187.21%

High 22 USD

Low 22 USD

Based on 1 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Based on 1 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,066.82

↑ +2.48%

JNJ

Johnson and Johnson

234.57

↑ +1.33%

ABBV

AbbVie Inc

216.12

↑ +0.45%

UNH

UnitedHealth Group Inc

388.17

↑ +1.5%

AZN

AstraZeneca PLC

187.25

↓-1.32%
help-icon Live chat